Disease modification upon brief exposure to tofacitinib during chronic epilepsy.
Hoffman OR, Koehler JL, Espina JEC, Patterson AM, Gohar ES, Coleman E, Schoenike BA, Espinosa-Garcia C, Paredes F, Varvel NH, Dingledine RJ, Maguire JL, Roopra AS.
Hoffman OR, et al. Among authors: patterson am.
bioRxiv [Preprint]. 2024 Nov 21:2023.08.07.552299. doi: 10.1101/2023.08.07.552299.
bioRxiv. 2024.
PMID: 37662337
Free PMC article.
Preprint.